Following The Money: Institution’s Growing Stake In Hologic, Inc (NASDAQ: HOLX)

Hologic, Inc (HOLX) concluded trading on Wednesday at a closing price of $61.47, with 3.26 million shares of worth about $200.48 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -25.67% during that period and on Wednesday the price saw a loss of about -0.82%. Currently the company’s common shares owned by public are about 225.56M shares, out of which, 222.47M shares are available for trading.

Stock saw a price change of 0.61% in past 5 days and over the past one month there was a price change of -3.85%. Year-to-date (YTD), HOLX shares are showing a performance of -14.73% which decreased to -19.02% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $60.33 but also hit the highest price of $84.67 during that period. The average intraday trading volume for Hologic, Inc shares is 2.42 million. The stock is currently trading -2.48% below its 20-day simple moving average (SMA20), while that difference is down -7.94% for SMA50 and it goes to -18.39% lower than SMA200.

Hologic, Inc (NASDAQ: HOLX) currently have 225.56M outstanding shares and institutions hold larger chunk of about 103.07% of that.

The stock has a current market capitalization of $13.79B and its 3Y-monthly beta is at 0.83. PE ratio of stock for trailing 12 months is 19.45, while it has posted earnings per share of $3.16 in the same period. Its PEG reads 2.50 and has Quick Ratio of 2.78 while making debt-to-equity ratio of 0.53. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for HOLX, volatility over the week remained 2.11% while standing at 2.21% over the month.

Stock’s fiscal year EPS is expected to rise by 4.59% while it is estimated to increase by 8.65% in next year.

Coverage by Leerink Partners stated Hologic, Inc (HOLX) stock as a Market perform in their note to investors on February 06, 2025, suggesting a price target of $75 for the stock. Stock get a Buy rating from Needham on December 10, 2024.

Most Popular

Related Posts